In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

03:44 EDT 26th May 2015 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,200+

Tuesday 19th May 2015

The Children's Hospital of Philadelphia to Launch Leukodystrophy Center of Excellence for Children with Degenerative Inherited White Matter Diseases

PHILADELPHIA, May 19, 2015 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia (CHOP) announced the launch of a Leukodystrophy Center of Excellence at the Calliope Joy Foundation's "An Evening with Jim and Jill Kelly" gala at the Rittenhouse Hotel on Friday, May 15. The leukodystrophies are a group of rare, inherited disorders that affect the white matter in the brain and spi...

Lakewood-Amedex Announces Its Novel Bisphospocin® Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis (MDR-TB) Strains In Fifteen Minutes

SARASOTA, Fla., May 19, 2015 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycob...

Decision Diagnostics States Johnson & Johnson Division Offers Partial Surrender in Long Running Patent Battle

LOS ANGELES, May 19, 2015 /PRNewswire/ -- Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip™ 50, the FDA cleared Green Glucose Test Strip, specifically designed to work with the market leading Johnson & Johnson's LifeScan OneTouch Ultra family of...

Sysmex America, Inc., Introduces New TS-10 Integrated Tube Sorter and Archiver for the XN-9000™ Lavender Top Management® Solution

LINCOLNSHIRE, Ill., May 19, 2015 /PRNewswire/ -- Sysmex America, Inc., a global leader in automated hematology diagnostics, today announces the introduction of the Sysmex TS-10™ Integrated Tube Sorter and Archiver for pre- and post-analytic tube management available for the Sysmex XN-9000™ Automated Hematology System. The TS-10 supports hands-free sorting and archiving and introdu...

ORIG3N™ Announces Strategic Collaboration with LabCorp

BOSTON, May 19, 2015 /PRNewswire/ -- ORIG3N, Inc., a pioneer in regenerative medicine and provider of induced pluripotent stem cell (iPSC) storage, called LifeCapsule (www.capsule.life), today announced a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH). LabCorp has invested in ORIG3N, and will provide storage fo

POCARED Announces Real Time Identification of Bacterial Species and Antibiotic Resistance Markers

REHOVOT, Israel, May 19, 2015 /PRNewswire/ -- POCARED Diagnostics, a leading in-vitro diagnostic and pre-analytical technologies manufacturer announces a breakthrough in real time identification of bacterial species and antibiotic resistance markers utilizing its proprietary technology in the P 1000. POCARED's P 1000™ is a rapid automated platform that employs intrinsic fluorescence; o...

An Interview with Swaine Chen, Genome Institute of Singapore and Further Group Discounts for the 2nd Annual Microbiology & Infectious Diseases Asia Congress

After the success of our inaugural event, Oxford Global Conferences are proud to announce the 2nd Annual Microbiology & Infectious Diseases Asia Congress will be taking place on the 23rd & 24th June 2015 in Singapore. Consisting of over 40 presentations across four interactive streams, the event is a unique opportunity for over 175 experts working in molecular diagnostics, microbiology, g...

Study: Lack of companion diagnostics hampers precision medicine's growth

Half the products in drugmakers' late-state oncology pipelines are based on biomarkers, but the FDA has approved only seven d -More- 

Big Returns For Oncology Investors

Patently successful and promising immune-oncology technologies, large markets, and attractive returns have factored into impressive investments in companies with cancer-targeting drugs or technologies. A five-plus-year study of fundraising for biopha...

Diaxonhit Grants Felicitex a Global Exclusive License of a Series of Lead-stage Anti-cancer Compounds against Quiescent Cancer Cells

Press Release Diaxonhit and Felicitex Therapeutics, Inc. Announce Global Exclusive License of a Series of Lead-stage Anti-cancer Compounds from Diaxonhit for the Development of Therapeutics against Quiescent Cancer Cells Paris, France and Cambridge, MA, USA - May 19, 2015 Diaxonhit (Alternext : ALEHT, FR0004054427), a French fully integrated leader in in vitro diagnostics, invol...

ESPERITE N.V. Trading Update. Q1 confirms strategy and forecasted growth with Genoma

The company is now building the future. CryoSave is on track and Genoma shows its ability to support the current published forecasts and ambitious next developments.   Zutphen, The Netherlands - 19 May 2015   ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces its trading update for the quarter ended 31 March 2015.  ESPERITE has accomplished signifi...

Pacific Fertility Center’s New Program Combines eSET and Comprehensive Chromosome Screening

Combining eSET with other technologies, Pacific Fertility Center is achieving unparalleled results and leading the charge for healthier pregnancies. San Francisco, CA (PRWEB) May 19, 2015 Unprecedented high pregnancy rates combined with low pregnancy risks: That’s the promise of elective single embryo transfer (eSET), when combined with comprehensive chromosome screening (CCS) and other technol...

Monday 18th May 2015

BioNTech Signs Co-Development and Commercialization Agreement in Immuno-Oncology

MAINZ, Germany, May 19, 2015 /PRNewswire/ -- Collaboration with Genmab will focus on novel bispecific antibody products in immuno-oncology   BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S (OMX: GEN) to jointly research, develop and commercialize multiple bispecifi...

Pharmaceutical Research: Characterization of efflux transport proteins of the human choroid plexus papilloma cell line HIBCPP, a functional in vitro model of the blood-cerebrospinal fluid barrier

Type: Original PaperPurposeTo characterize the human choroid plexus (CP) papilloma cell line HIBCPP with respect to ABC export protein expression and function in order to evaluate its use as an in vitro model to study carrier-mediated transport proce...

The AAPS Journal: The Role of Megalin in the Transport of Gentamicin Across BeWo Cells, an In Vitro Model of the Human Placenta

Type: Original PaperAminoglycosides (AG) are known to readily cross the placenta, although the mechanisms responsible for placental transport have not been characterized. Megalin is expressed in human placenta, and it is reasonable to speculate, give...

AAPS PharmSciTech: Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System

Type: Original PaperThe in vitro assessment of drug release from polymeric nanocapsules suspensions is one of the most studied parameters in the development of drug-loaded nanoparticles. Nevertheless, official methods for the evaluation of drug relea...

AAPS PharmSciTech: Effect of Simultaneous Administration of Dihydroxyacetone on the Diffusion of Lawsone Through Various In Vitro Skin Models

Type: Original PaperUnprotected sunlight exposure is a risk factor for a variety of cutaneous cancers. Topically used dihydroxyacetone (DHA) creates, via Maillard reaction, chemically fixed keratin sunscreen in the stratum corneum with significant pr...

Response Biomedical Corp. Announces the Appointment of Dr. Barbara Kinnaird Ph.D. as Chief Executive Officer and Voting Results from its 2015 AGM

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/19/15 -- The Board of Directors of Response Biomedical Corp. (TSX: RBM)(OTCQB: RPBIF) ("Response" or "the Company"), is pleased to announce the promotion of Dr. Barbara Kinnaird Ph.D. to the position of Chief Executive Officer effective immediately. The Board would like to thank Dr. Anthony (Tony) Holler for his service as Interim Chief Executiv...

Veteran Dental Executive Harold C. Flynn Jr. to Become President and CEO of BIOLASE

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that veteran dental industry executive Harold C. Flynn Jr. will become President and Chief Executive Officer, effective July 13, 2015. The current President and CEO Jeffrey M. Nugent will step down at that time. Flynn, 50, has more than 25 years of senior executive ex...

Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc. and Roche Molecular Systems, Inc.

Illumina (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc. and its parent company, Roche Molecular Systems, Inc. Illumina is seeking all available remedies. The new suit, filed in the U.S. District Court for the Northern District of California, is based on Ariosa’s infringeme...

Florida Governor Rick Scott Visits Tampa-based Inspirata to Applaud its Cancer Diagnostics Solution and the Accompanying Bio-tech Jobs it is Generating

The company launched its unique digital pathology workflow solution last March at the United States and Canadian Academy of Pathology Annual Meeting in Boston. Tampa, FL (PRWEB) May 18, 2015 Cancer diagnostics solution provider, Inspirata, Inc. was visited today by Florida’s top elected official, Governor Rick Scott, who had a positive message to deliver about the company’s job creation and p...

Genzyme, Ablynx partner in MS

Ablynx N.V. (Euronext:ABLX) and the Genzyme Corp. unit of Sanofi (Euronext:SAN; NYSE:SNY) partnered to develop Nanobodies against an undisclosed multiple sclerosis target. Ablynx's Nanobodies are therapeutic proteins based on single-domain antibody f...

GE Webinar Provides Guidance on Protein Purification Techniques for Laboratory Scale

The Webinar will discuss the introduction of a proven protein purification strategy, called CiPP (Capture, Intermediate purification, Polishing), May 19, 2015 (PRWEB) May 18, 2015 It might be a surprise to learn it does not take a herculean effort to make great strides in a chromatography workflow. Adopting small changes and making decisions with forethought can make all the difference. Clarifyi...

Luminex Corporation To Present At Jefferies 2015 Healthcare Conference

AUSTIN, Texas, May 18, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2015 Global Healthcare Conference to be held June 1-4, 2015, in New York City, NY. The investor presentation will begin at 2:00 p.m. Eastern time on Wednesday, June 3, 2015.  The presentation will be webcast live and may be accessed at Lumine...

Scientists at the Center for Infectious Disease Research Discover How Lethal Parasites Control Their Escape from the Immune System

New parasitic discovery may aid in treatment of Human African Trypanosomiasis Scientists at the Center for Infectious Disease Research have discovered how parasites that cause the lethal disease Human African Trypanosomiasis and other related diseases in animals control the process that allows them to evade elimination by the immune system throu...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks